» Articles » PMID: 38189894

Understanding the Link Between Neurotropic Viruses, BBB Permeability, and MS Pathogenesis

Overview
Journal J Neurovirol
Publisher Springer
Specialties Microbiology
Neurology
Date 2024 Jan 8
PMID 38189894
Authors
Affiliations
Soon will be listed here.
Abstract

Neurotropic viruses can infiltrate the CNS by crossing the blood-brain barrier (BBB) through various mechanisms including paracellular, transcellular, and "Trojan horse" mechanisms during leukocyte diapedesis. These viruses belong to several families, including retroviruses; human immunodeficiency virus type 1 (HIV-1), flaviviruses; Japanese encephalitis (JEV); and herpesviruses; herpes simplex virus type 1 (HSV-1), Epstein-Barr virus (EBV), and mouse adenovirus 1 (MAV-1). For entering the brain, viral proteins act upon the tight junctions (TJs) between the brain microvascular endothelial cells (BMECs). For instance, HIV-1 proteins, such as glycoprotein 120, Nef, Vpr, and Tat, disrupt the BBB and generate a neurotoxic effect. Recombinant-Tat triggers amendments in the BBB by decreasing expression of the TJ proteins such as claudin-1, claudin-5, and zona occludens-1 (ZO-1). Thus, the breaching of BBB has been reported in myriad of neurological diseases including multiple sclerosis (MS). Neurotropic viruses also exhibit molecular mimicry with several myelin sheath proteins, i.e., antibodies against EBV nuclear antigen 1 (EBNA1) aa411-426 cross-react with MBP and EBNA1 aa385-420 was found to be associated with MS risk haplotype HLA-DRB1*150. Notably, myelin protein epitopes (PLP, MOG, and MBP) are being used to generate model systems for MS such as experimental autoimmune encephalomyelitis (EAE) to understand the disease mechanism and therapeutics. Viruses like Theiler's murine encephalomyelitis virus (TMEV) are also commonly used to generate EAE. Altogether, this review provide insights into the viruses' association with BBB leakiness and MS along with possible mechanistic details which could potentially use for therapeutics.

Citing Articles

The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Interpreting the role of epigallocatechin-3-gallate in Epstein-Barr virus infection-mediated neuronal diseases.

Rani A, Saini V, Njini N, Dixit A, Meena A, Jha H Folia Microbiol (Praha). 2025; .

PMID: 39849283 DOI: 10.1007/s12223-025-01240-0.


Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodies.

Callahan V, Sutton M, Gardner C, Kenchegowda D, Dunagan M, Gosavi M bioRxiv. 2024; .

PMID: 39605662 PMC: 11601667. DOI: 10.1101/2024.11.03.619087.


Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier.

Cazalla E, Cuadrado A, Garcia-Yague A Fluids Barriers CNS. 2024; 21(1):93.

PMID: 39574123 PMC: 11580557. DOI: 10.1186/s12987-024-00599-5.


Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy.

Yang S, Sun Y, Liu W, Zhang Y, Sun G, Xiang B Cancers (Basel). 2024; 16(4).

PMID: 38398214 PMC: 10887132. DOI: 10.3390/cancers16040823.

References
1.
Ajasin D, Eugenin E . HIV-1 Tat: Role in Bystander Toxicity. Front Cell Infect Microbiol. 2020; 10:61. PMC: 7052126. DOI: 10.3389/fcimb.2020.00061. View

2.
Alimonti J, Ribecco-Lutkiewicz M, Sodja C, Jezierski A, Stanimirovic D, Liu Q . Zika virus crosses an in vitro human blood brain barrier model. Fluids Barriers CNS. 2018; 15(1):15. PMC: 5952854. DOI: 10.1186/s12987-018-0100-y. View

3.
Alves-Leon S, Lima M, Nunes P, Chimelli L, Rabelo K, Nogueira R . Zika virus found in brain tissue of a multiple sclerosis patient undergoing an acute disseminated encephalomyelitis-like episode. Mult Scler. 2018; 25(3):427-430. DOI: 10.1177/1352458518781992. View

4.
Andras I, Pu H, Deli M, Nath A, Hennig B, Toborek M . HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res. 2003; 74(2):255-65. DOI: 10.1002/jnr.10762. View

5.
Assetta B, Atwood W . The biology of JC polyomavirus. Biol Chem. 2017; 398(8):839-855. DOI: 10.1515/hsz-2016-0345. View